Evidence map›Paper›PMID 27487993›Full record

Trial reportScientific reports2016

The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study.

Robert Carreras-Torres, Philip C Haycock, Caroline L Relton, Richard M Martin, George Davey Smith, Peter Kraft, Chi Gao, Shelley Tworoger, Loïc Le Marchand, Lynne R Wilkens and 18 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. ISSLS Prize in Clinical Science 2020. Examining causal effects of body mass index on back pain: a Mendelian randomization study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020 · on this map
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 5 countries.

Robert Carreras-TorresSection of Genetics, International Agency for Research on Cancer (IARC), Lyon, France.
Philip C HaycockMRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Caroline L ReltonMRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Richard M MartinMRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
George Davey SmithMRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Peter KraftDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
Chi GaoDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
Shelley TworogerDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
Loïc Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.
Lynne R WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.
Sungshim L ParkNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA.
Christopher HaimanNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA.
John K FieldRoy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, UK.
Michael DaviesRoy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, UK.
Michael MarcusRoy Castle Lung Cancer Research Programme, The University of Liverpool Cancer Research Centre, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, The University of Liverpool, Liverpool, UK.
Geoffrey LiuOntario Cancer Institute, Princess Margaret Cancer Center, Toronto, ON, Canada.
Neil E CaporasoGenetic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Rockville, USA.
David C ChristianiDepartments of Environmental Health and Epidemiology, Harvard T. H. Chan School of Public Health and Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, USA.
Yongyue WeiDepartments of Environmental Health and Epidemiology, Harvard T. H. Chan School of Public Health and Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, USA.
Chu ChenProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA.
Jennifer A DohertyDepartment of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, USA.
Gianluca SeveriHuman Genetics Foundation (HuGeF), Torino, Italy.
Gary E GoodmanFred Hutchinson Cancer Research Center, Seattle, USA.
Rayjean J HungLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
Christopher I AmosDepartment of Biomedical Data Science, Geisel School of medicine, Dartmouth College, Lebanon, USA.
James McKaySection of Genetics, International Agency for Research on Cancer (IARC), Lyon, France.
Mattias JohanssonSection of Genetics, International Agency for Research on Cancer (IARC), Lyon, France.
Paul BrennanSection of Genetics, International Agency for Research on Cancer (IARC), Lyon, France.
Centre International de Recherche sur le Cancer · FRUniversity of Bristol · GBHarvard University · USUniversity of Liverpool · GBDartmouth College · USFred Hutch Cancer Center · USMassachusetts General Hospital · USUniversity of Southern California · USItalian institute for Genomic Medicine · ITLunenfeld-Tanenbaum Research Institute · CANational Cancer Institute · USOntario Institute for Cancer Research · CAUniversity of Hawaii Cancer CenterUniversity of Hawaii System · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GERTRAUD MASKARINEC · 1996 to 2026
$56.2M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)U01CA063673 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOODMAN, GARY E · 1994 to 2006
$13.0M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORYUM1CA167462 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOODMAN, GARY E · 2013 to 2017
$2.8M
Cancer Research UK 19169Cancer Research UK 20138Cancer Research UK A19169Medical Research Council MC_UU_12013/1Medical Research Council MC_UU_12013/2NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA023108NCI NIH HHS P30 CA071789NCI NIH HHS R01 CA049449NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA063673NCI NIH HHS UM1 CA167462NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA186107World Health Organization 001
6 · The paper itself

Abstract

Body mass index (BMI) is inversely associated with lung cancer risk in observational studies, even though it increases the risk of several other cancers, which could indicate confounding by tobacco smoking or reverse causality. We used the two-sample Mendelian randomization (MR) approach to circumvent these limitations of observational epidemiology by constructing a genetic instrument for BMI, based on results from the GIANT consortium, which was evaluated in relation to lung cancer risk using GWAS results on 16,572 lung cancer cases and 21,480 controls. Results were stratified by histological subtype, smoking status and sex. An increase of one standard deviation (SD) in BMI (4.65 Kg/m(2)) raised the risk for lung cancer overall (OR = 1.13; P = 0.10). This was driven by associations with squamous cell (SQ) carcinoma (OR = 1.45; P = 1.2 × 10(-3)) and small cell (SC) carcinoma (OR = 1.81; P = 0.01). An inverse trend was seen for adenocarcinoma (AD) (OR = 0.82; P = 0.06). In stratified analyses, a 1 SD increase in BMI was inversely associated with overall lung cancer in never smokers (OR = 0.50; P = 0.02). These results indicate that higher BMI may increase the risk of certain types of lung cancer, in particular SQ and SC carcinoma.

Indexed as

Body Mass IndexCase-Control StudiesFemaleHumansLung NeoplasmsMaleMendelian Randomization AnalysisRisk FactorsSmoking

Identifiers

PMID27487993
PMCPMC4973233
OpenAlexW2499691332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.